MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 4, Pages e1117738
Publisher
Informa UK Limited
Online
2016-01-07
DOI
10.1080/2162402x.2015.1117738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
- (2015) M. J. Schliekelman et al. CANCER RESEARCH
- Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
- (2015) M. Hasegawa et al. CLINICAL CANCER RESEARCH
- MUC1-C activates the TAK1 inflammatory pathway in colon cancer
- (2015) H Takahashi et al. ONCOGENE
- Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
- (2015) Duane H. Hamilton et al. Oncotarget
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
- (2015) C. R. Heery et al. Cancer Immunology Research
- Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
- (2015) Duane H. Hamilton et al. Oncotarget
- Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
- (2015) Maroof Alam et al. Oncotarget
- MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
- (2015) Akriti Kharbanda et al. Oncotarget
- MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter
- (2014) Viviane Gnemmi et al. CANCER LETTERS
- WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition
- (2014) D. H. Hamilton et al. CANCER RESEARCH
- T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness
- (2014) F. Pinto et al. CLINICAL CANCER RESEARCH
- Brachyury: A Diagnostic Marker for the Differential Diagnosis of Chordoma and Hemangioblastoma versus Neoplastic Histological Mimickers
- (2014) Valeria Barresi et al. DISEASE MARKERS
- Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma
- (2014) Michael J. Kelley et al. HUMAN GENETICS
- Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis
- (2014) Claudia Palena et al. JNCI-Journal of the National Cancer Institute
- A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
- (2013) Michael A. Morse et al. ANNALS OF SURGERY
- Expression of Brachyury Gene Is a Significant Prognostic Factor for Primary Lung Carcinoma
- (2013) Akira Haro et al. ANNALS OF SURGICAL ONCOLOGY
- Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
- (2013) Caroline Jochems et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
- (2013) I. Akalay et al. CANCER RESEARCH
- An Autocrine Loop between TGF- 1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype
- (2013) C. Larocca et al. MOLECULAR CANCER THERAPEUTICS
- The epigenetics of epithelial-mesenchymal plasticity in cancer
- (2013) Wai Leong Tam et al. NATURE MEDICINE
- MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial–mesenchymal transition
- (2013) H Rajabi et al. ONCOGENE
- The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies
- (2013) B Huang et al. Cell Death & Disease
- An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
- (2013) R Y-J Huang et al. Cell Death & Disease
- Expression of Brachyury in Hemangioblastoma
- (2012) Valeria Barresi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- CCL2 is critical for immunosuppression to promote cancer metastasis
- (2012) Chie Kudo-Saito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
- (2012) M. Roselli et al. CLINICAL CANCER RESEARCH
- MUC1 immunotherapy is here to stay
- (2012) Takashi Kimura et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The MUC1-C Oncoprotein Binds to the BH3 Domain of the Pro-apoptotic BAX Protein and Blocks BAX Function
- (2012) Rehan Ahmad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
- (2011) R. I. Fernando et al. CANCER RESEARCH
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
- (2011) M. Mohebtash et al. CLINICAL CANCER RESEARCH
- Brachyury expression predicts poor prognosis at early stages of colorectal cancer
- (2011) Nerbil Kilic et al. EUROPEAN JOURNAL OF CANCER
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
- (2011) D. Raina et al. MOLECULAR CANCER THERAPEUTICS
- Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer
- (2010) P. L. Beatty et al. Cancer Prevention Research
- miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death
- (2010) Kufe INTERNATIONAL JOURNAL OF ONCOLOGY
- The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
- (2010) Romaine I. Fernando et al. JOURNAL OF CLINICAL INVESTIGATION
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- Brachyury Expression in Extra-axial Skeletal and Soft Tissue Chordomas: A Marker that Distinguishes Chordoma From Mixed Tumor/Myoepithelioma/Parachordoma in Soft Tissue
- (2009) Roberto Tirabosco et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
- (2009) Chie Kudo-Saito et al. CANCER CELL
- Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells
- (2009) D. Raina et al. CANCER RESEARCH
- MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
- (2009) M. Sachdeva et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- MUC1 oncoprotein is a druggable target in human prostate cancer cells
- (2009) M. D. Joshi et al. MOLECULAR CANCER THERAPEUTICS
- T (brachyury) gene duplication confers major susceptibility to familial chordoma
- (2009) Xiaohong R Yang et al. NATURE GENETICS
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MUC1 Oncoprotein Blocks Death Receptor-Mediated Apoptosis by Inhibiting Recruitment of Caspase-8
- (2008) N. Agata et al. CANCER RESEARCH
- Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy
- (2008) Stuart Thomson et al. CLINICAL & EXPERIMENTAL METASTASIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started